Amy Wang
Analyst-Equity at Public Ventures LLC
Profile
Dr. Amy Wang is a Managing Director-Investment Banking at Public Ventures LLC.
She joined Public Ventures in 2007 to support and further the endeavors in life science and healthcare.
Prior to joining Public Ventures, Dr. Wang was a development scientist at Invitrogen Corp.'s Biosource division where she led a team in the Signal Transduction Assay group and spearheaded development of the Epigenetics program.
Prior to Invitrogen, she served as a staff scientist at Amcyte, Inc., a type I diabetes cell therapy biotech (acquired by ReNeuron).
She was a post-doctoral fellow at UCLA in Michael Grunstein's laboratory where she worked on chromatin modifications and gene regulation.
Dr. Wang received her BS in Biochemistry, MBA and PhD from UCLA.
Amy Wang active positions
| Companies | Position | Start |
|---|---|---|
Public Ventures LLC
 Public Ventures LLC Investment Banks/BrokersFinance Public Ventures LLC is a registered broker-dealer headquartered in Dallas, Texas. The firm was founded by Christopher Marlett and Anthony DiGiandomenico in 1997. They are a wholly-owned subsidiary of MDB Capital Holdings LLC. Public Ventures offers Go-to-Market Strategy, Market Assessments, Revenue Generation and Product Strategy for technology companies that targets the Public Sector. | Analyst-Equity | 2007-04-30 |
Former positions of Amy Wang
| Companies | Position | End |
|---|---|---|
| CUE BIOPHARMA, INC. | Director/Board Member | - |
AmCyte, Inc.
 AmCyte, Inc. Pharmaceuticals: MajorHealth Technology Part of ReNeuron Group Plc, AmCyte, Inc. provides safe and effective cell therapy for patients with diabetes. The company is based in Santa Monica, CA. AmCyte was acquired by ReNeuron Group Plc on July 27, 2007 for $4.46 million. | Corporate Officer/Principal | - |
Training of Amy Wang
| University of California, Los Angeles | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CUE BIOPHARMA, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Public Ventures LLC
Public Ventures LLC Investment Banks/BrokersFinance Public Ventures LLC is a registered broker-dealer headquartered in Dallas, Texas. The firm was founded by Christopher Marlett and Anthony DiGiandomenico in 1997. They are a wholly-owned subsidiary of MDB Capital Holdings LLC. Public Ventures offers Go-to-Market Strategy, Market Assessments, Revenue Generation and Product Strategy for technology companies that targets the Public Sector. | Finance |
AmCyte, Inc.
AmCyte, Inc. Pharmaceuticals: MajorHealth Technology Part of ReNeuron Group Plc, AmCyte, Inc. provides safe and effective cell therapy for patients with diabetes. The company is based in Santa Monica, CA. AmCyte was acquired by ReNeuron Group Plc on July 27, 2007 for $4.46 million. | Health Technology |
- Stock Market
- Insiders
- Amy Wang
